NASDAQ · COEP
Healthcare · Biotechnology
$16.40
Down-$1.03 (-8.57%)
Updated Aug 13, 2026, 3:44 PM
SID Score
4.7/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
COEP does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning COEP.
COEP research
Company profile and research snapshot.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 22, 2023 | Ladenburg Thalmann | Buy | — |
| May 18, 2023 | EF Hutton | Buy | — |
| May 10, 2023 | EF Hutton | Buy | — |
| Apr 19, 2023 | JonesTrading | Buy | — |
| Apr 5, 2023 | EF Hutton | Buy | — |
No generated briefing is available yet.
Benzinga · Feb 5, 2026
Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) ("Coeptis" or the "Company"), a next-gen technology and biopharmaceutical company, today announced that its shareholders have voted to approve the previously announced
Yahoo · Jan 6, 2026
BRISTOL, TN / ACCESS Newswire / January 6, 2026 /The Vanderbilt Report today published coverage of Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) following the company's recent SEC filings detailing a merger transaction with Z-Squared, Inc. According ...
defenseworld.net · Dec 11, 2025
Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP - Get Free Report)'s share price fell 3.6% during mid-day trading on Wednesday. The stock traded as low as $15.00 and last traded at $15.05. 157,665 shares traded hands during mid-day trading, an increase of 107% from the average session volume of 76,094 shares. The stock had previously closed
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning COEP.
